Looking to give back before year end? Check out the AZBio Annual Giving GuideContinue reading
Author Archive: AZBio
TGen’s Dr. Von Hoff is named a ‘Giant of Cancer Care’
Honor recognizes the devotion of time, talent and resources to improving the care of cancer patients
US Food and Drug Administration awards Critical Path Institute 3 grants, 1 contract
The US Food and Drug Administration (FDA) has awarded Critical Path Institute (C-Path) three grants to develop data standards, as well as a contract to continue its research into drug-induced kidney injury. With these awards, the FDA continues to support C‑Path’s efforts to advance translational research toward accelerating drug development and regulatory review.Continue reading
Avery Therapeutics wins Get Started Tucson pitch competition
Avery Therapeutics, a company working toward commercializing a beating heart graft technology, won $60,000 in cash and services.Continue reading
NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis.
NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer”.Continue reading
Critical Path Iinstitute and CHDI Foundation, Inc. Establish a Consortium to Expedite Approval of Huntington’s Disease Therapeutics
Critical Path Institute (C-Path) and CHDI Foundation, Inc. (CHDI), are collaborating to set up a broad-based consortium that will more clearly define regulatory pathways leading to the approval of Huntington’s disease (HD) therapeutics.Continue reading
Scott Hathcock Named CEO of NACET
Scott Hathcock has worked for two years at the Chamber as vice president of business development and brings a strong entrepreneurial track record to the NACET Team.Continue reading
Designed to Accelerate Health Innovation, Trinnovate Ventures Invests in Four New Start-Ups
Trinnovate Ventures, Inc., a new organization focused on accelerating healthcare innovation, has partnered with four companies and is seeking additional proposals for consideration.Continue reading
To Treat the Heart, Neurotechnology Aims to Balance the Brain
Brain State Technologies (Scottsdale, Arizona) has announced that use of their allostatic neurotechnology was associated with positive effects for the cardiovascular system and reduction of inflammation, in individuals with diverse health conditions. The findings are being presented at the Council on Hypertension of the American Heart Association, meeting in Orlando, Florida from September 14-17.Continue reading
TB-REFLECT: A COLLABORATIVE EFFORT TO ENHANCE TB CLINICAL RESEARCH
TUCSON, October 25, 2016 – The Critical Path Institute’s (C-Path) Critical Path to TB Drug Regimens (CPTR) initiative and the Global TB Programme of the World Health Organization (WHO) have partnered with researchers from the University of California, San Francisco (UCSF), to develop leading-edge quantitative analyses of data from the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS)database. This collaboration, called TB-ReFLECT, will extract from these analyses key lessons from the TB-PACTS platform, and then package such lessons as tools for future TB trial design.Continue reading